CIK 0002058707 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Attovia Therapeutics, Inc.
Sign in to watch- Ticker
- ATTO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 921510574
- Phone
- 5103995001
- Business address
- 1091 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 3/A Insider 3/A
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 4/A Open-market buy Director bought 585,000 shares at an average $17.58 ($10,285,000)
- 4/A Open-market buy Former 10% Owner bought 585,000 shares at an average $17.58 ($10,285,000)
- 4 Open-market buy Director bought 585,000 shares at an average $17.58 ($10,285,000)
- 4 Open-market buy Former 10% Owner bought 585,000 shares at an average $17.58 ($10,285,000)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 1,957,138 shares (conversion)
- 4 Open-market buy 10% owner bought 382,352 shares at $17.00 ($6,499,984)
- 4 Open-market buy 10% owner bought 600,000 shares at $17.00 ($10,200,000)
- 4 Open-market buy 10% owner bought 300,000 shares at $17.00 ($5,100,000)
- 4 Open-market buy 10% owner bought 588,235 shares at $17.00 ($9,999,995)
Page 1 of 3 · 58 filings